Los puntos clave no están disponibles para este artículo en este momento.
In the wake of escalating medicine prices worldwide, Veronika Wirtz and colleagues argue for refocusing the WHO Model List of Essential Medicines on the needs of low and middle income countries, while retaining its global relevance as a model process
Wirtz et al. (Tue,) studied this question.